Unique ID issued by UMIN | UMIN000048902 |
---|---|
Receipt number | R000055721 |
Scientific Title | Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1) |
Date of disclosure of the study information | 2022/09/10 |
Last modified on | 2023/03/13 15:52:16 |
Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Japan |
Non-small cell lung cancer
Chest surgery |
Malignancy
NO
An ancillary study will be conducted on patients enrolled in the JCOG0707, "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer", to elucidate the frequency of the late recurrence of lung cancer and the sites most likely to recur, based on the long-term follow-up data. In addition, the relationship between the death from primary lung cancer and the death from other disease will be assessed by examining the frequency of secondary cancers and the causes of deaths from other diseases. Furthermore, the relationship between deaths from secondary cancers and deaths from non-cancer causes among other disease deaths will be ascertained.
Others
To elucidate the long-term prognosis after surgery for early-stage lung cancer
Exploratory
Not applicable
Overall survival
Recurrence-free survival, site of recurrence, cumulative incidence of secondary cancer, cumulative incidence of death from primary lung cancer, cumulative incidence of all causes of deaths (deaths from cancers and deaths from non-cancer causes)
Observational
Not applicable |
Not applicable |
Male and Female
Total 963 patients registered for the JCOG0707: "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non- small cell lung cancer"
Not applicable
963
1st name | Hideo |
Middle name | |
Last name | Kunitoh |
Japanese Red Cross Medical Center
Medical Oncology
150-8935
4-1-22, Hiroo, Shibuya-ku, Tokyo
03-3400-1311
kunito_hideo@med.jrc.or.jp
1st name | Masaya |
Middle name | |
Last name | Yotsukura |
JCOG0707A1 Coordinating Office
National Cancer Center Hospital, Department of Thoracic Surgery
104-0045
5-1-1, Tsukiji, Chuo-ku, Tokyo
03-3542-2511
http://www.jcog.jp/
mayotsuk@ncc.go.jp
Japan Clinical Oncology Group (JCOG)
National Cancer Center
Japanese Governmental office
Japan
National Cancer Center Institutional Review Board
5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan
03-3542-2511
irst@ncc.go.jp
NO
2022 | Year | 09 | Month | 10 | Day |
Unpublished
963
No longer recruiting
2022 | Year | 04 | Month | 06 | Day |
2022 | Year | 06 | Month | 03 | Day |
2022 | Year | 06 | Month | 03 | Day |
2025 | Year | 04 | Month | 06 | Day |
In this study, all patients enrolled in the JCOG0707 will be subjected to a prognostic survey; the analysis will be based on the existing data of the JCOG0707 stored at the JCOG Data Center and the data obtained from the prognostic survey in this study.
2022 | Year | 09 | Month | 10 | Day |
2023 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055721